Schedule 13G ownership disclosure

SILEXION THERAPEUTICS CORP

Ordinary shares, par value $0.0135 per share · CUSIP: G1281K130

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Mitchell P. Kopin

    Shares: 325,000.00 · Class: 9.4%

  • Daniel B. Asher

    Shares: 325,000.00 · Class: 9.4%

  • Intracoastal Capital LLC

    Shares: 325,000.00 · Class: 9.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-26-016532
Form type
SCHEDULE 13G/A
Filer
INTRACOASTAL CAPITAL, LLC
CIK
CIK 1646799
Filed
Feb 13, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub